日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension

乳腺癌揭示了与BMPR2相关的潜在肺动脉高压易感性

Toro, Victoria; Mougin, Manon; Brossat, Coline; Jambon-Barbara, Clement; Hlavaty, Alex; Guay, Charles Antoine; El Kabbout, Reem; Bilodeau, Coralie; Grobs, Yann; Martineau, Sandra; Breuils-Bonnet, Sandra; Abi-Sleimen, Antonella; Ruffenach, Gregoire; Boucherat, Olivier; Bisserier, Malik; Provencher, Steeve; Bonnet, Sebastien; Montani, David; Khouri, Charles; Potus, François

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design

第二代和第三代 BCR-ABL 酪氨酸激酶抑制剂与肺动脉高压风险:一项针对新用户的普遍研究

Jambon-Barbara, Clément; Suissa, Samy; Dell'Aniello, Sophie; Hlavaty, Alex; Cracowski, Jean-Luc; Chaumais, Marie-Camille; Humbert, Marc; Montani, David; Khouri, Charles

Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons

系统性硬化症肺动脉高压的治疗:从传统疗法到新方向

Villa, Annalisa; Sanges, Sébastien; Sobanski, Vincent; Lamblin, Nicolas; Rosato, Edoardo; Godinas, Laurent; Hachulla, Eric; Delcroix, Marion; Montani, David; Launay, David

Pulmonary hypertension associated with nonparenchymal restrictive lung diseases

与非实质性限制性肺疾病相关的肺动脉高压

Jutant, Etienne-Marie; Humbert, Marc; Montani, David; Khoury, Johad; Adir, Yochai

A 45-Year-Old Woman With Hereditary Hemorrhagic Telangiectasia and Persistent Exertional Dyspnea and Peripheral Edema

一名45岁女性,患有遗传性出血性毛细血管扩张症,并持续出现劳力性呼吸困难和外周水肿。

Triantafyllidi, Helen; Birmpa, Dionysia; Fambri, Anastasia; Benas, Dimitrios; Montani, David

Pulmonary hypertension associated with COPD: exploring the complex spectrum of an unmet clinical challenge

慢性阻塞性肺疾病相关肺动脉高压:探索尚未满足的临床挑战的复杂谱系

Riou, Marianne; Beurnier, Antoine; Montani, David

Adult male patients with DKC1 mutations present early-onset pulmonary fibrosis and severe prognosis

携带 DKC1 基因突变的成年男性患者会出现早发性肺纤维化,预后不良。

Evrard, Ophélie; Philippot, Quentin; Kannengiesser, Caroline; Debray, Marie Pierre; Guyard, Alice; Fattori, Antonin; Schuller, Armelle; Nunes, Hilario; Montani, David; Bours, Vincent; Cottin, Vincent; Traclet, Julie; Benattia, Amira; Berthoux, Emilie; Daniel, Adrien; Yan-Min, Xu; Lainey, Elodie; Saussereau, Julien; Chelbi Viallon, Malika; Oudin, Claire; Morel, Héléne; Crestani, Bruno; Borie, Raphaël; Ba, Ibrahima

Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study

重症 COVID-19 期间使用白细胞介素-6 受体抑制剂的获益和风险:一项回顾性多中心研究

Lefèvre, Charlène; Funck-Brentano, Théo; Cachanado, Marine; Plocque, Alexia; Youinou, Maëlle; Fels, Audrey; Pène, Frédéric; Savale, Laurent; Montani, David; Voisin, Olivier; Bintein, Flore; Wildenberg, Lucille; Philippe, Axel; Legriel, Stéphane; Roche, Nicolas; Burgel, Pierre-Régis; Tran, Marc; Noël, Nicolas; Baillard, Christophe; Duranteau, Jacques; Chatellier, Gilles; Philippart, Francois

Genetic analysis and clinical phenotype of pulmonary arterial hypertension in an Algerian population

阿尔及利亚人群肺动脉高压的基因分析和临床表型

Berkane, Amel Wafa; Yahiaoui, Rachida; Methia, Nadéra; Djami-Temim, Nassima; Coulet, Florence; Antigny, Fabrice; Montani, David; Hamouli-Said, Zohra

Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension

SGLT2(钠-葡萄糖协同转运蛋白2)抑制剂在肺动脉高压中的应用

Aguado, Benoit; Ruffenach, Grégoire; Lacoste-Palasset, Thomas; Görlach, Agnes; Riou, Marianne; Gourmelon, Mathieu; Bauer, Fabrice; Humbert, Marc; Schini-Kerth, Valerie; Vachiéry, Jean-Luc; Montani, David; Antigny, Fabrice